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Rat aldolase A gene has 2 promoters with different issue specificities (M- and AH promoters). The M promoter isactive only in adult skeletal 
muscle and induced uring myogenesis, whereas the AH promoter isactive ubiquitously in many tissues, including various cancer cells. Regulatory 
sequences for these promoters were investigated through assays for transient expression after introduction i to myogenic and nonmyogenic cells. 
When M promoter-CAT fusion genes were transfected into primary cultures of chicken myoblasts, expression of CAT activity was drastically 
induce d during myotube formation. The region comprising 202 to 85 base pairs (bp) upstream from the transcription i itiation site was found to 
be necessary for the induction and an enhancer activity whose region includes the AT-rich recognition sequence (MEF-2 binding site). On the other 
hand. 2 upstream regions were found to be responsible for AH promoter activity expressed in HepG2 cells. The distal region (-280 to -260) of 
the promoter includes the API binding sequence, whereas the proximal region (-207 to -180) contains a novel inverted repeat consisting of 22 
bp but does not contain known promoter and enhancer sequences. 
Aldolase A; Promoter; CAT assay; Gene expression; Rat 
I. INTRODUCTION 
AldolaseA is one of 3 is.0zymic forms of fructose 
1,6-bisphosphate aldolase and exists ubiquitously and 
abundantly in many tissues, especially in skeletal muscle 
[1,2]. 
Recently we found that a single gene of rat aldolase 
A has multiple promoters to allow the tissue-specific 
generation of mRNA differing in their untranslated re- 
gions by alternative usage of the leading exons [3]. The 
first exon, designated M1, encodes the 5' untranslated 
sequence specific for M-type mRNA, whereas the sec- 
ond exon, AH1, encodes the 5' untranslated sequences 
specific for AH-type mRNAs. Distribution of the 2 
types of mRNAs should be primarily determined by 
tissue-specific activities of the 2 promoters of the lead- 
ing exons, which are designated as M- and AH promo- 
ters, respectively. M-type mRNA is expressed exclusive- 
ly and highly abundantly in adult skeletal muscle [4,5]. 
This expression was found to be induced during 
myotube formation from myoblasts of established cell 
lines of rat and mice (unpublished results and [6]). On 
the other hand, AH-type mRNAs are widely expressed 
to produce aldolase A in many tissues such as brain, 
spleen, and heart, and in cancer cells [4,5]. 
In order to elucidate the regulatory mechanisms for 
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tissue-specific usages of the 2 promoter  s in a single gene, 
we have begun to identify c/s-acting regulatory elements 
in the promoter regions. This communication describes 
that a 300 base pair (bp) upstream region of  the AH 
promoter where 2 positive elements are identified is 
sufficient for the promoter activity in HepG2 cells, while 
the region from -202 to -85 of the M promoter is 
responsible for dramatic activation during the differen- 
tiation of  chicken primary myoblast cells. 
2. MATERIALS  AND METHODS 
2.1. Cell culture 
Chicken primary myoblast cultures were prepared from breast n~us- 
cles of I 1 -day-old chicken embryos essentially as described [7]. Human 
hepatoma cell line, HepG2 [8], was grown in Eaglffs minimal essential 
medium (Nissui) containing 5% fetal calf serum. 
2.2. Construction fCA T fusio, genes 
pM-CAT and pAH-CAT fusion genes were constructed by inser- 
ting either of the promoter f agments of the rat aldolase A genomic 
gene into pOA/CAT, a promoterless CAT plasmid [9], at BamHI 
and/or Hhtdlll sites just upstre~lm of the CAT coding region. 5' dele- 
tion mutants of pM-CAT fusion genes were constructed by digesting 
the promoter fragment with appropriate restriction endonucleases. 
For pM85.a+CAT and pM85.a-CAT, the fragment spanning from 
-85 to -202 was inserted into the Aatll site in the pBR322 region of 
pM85CAT in either orientation. 5' deletion mutants of pAH-CAT 
were generated by digesting the 5' end of the promoter fragment with 
Bal31 exonucleasc and ligating the digested end to the vector with 
BamHI-linker. Linker-scanning and internal deletion mutants of 
pAH293CAT were constructed by combining a pair of 5' and 3' dele- 
tion mutants of pAH-CAT having the appropriate deletion ends. 
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2.3. DNA transfection 
DNA transfection was performed by the method of calcium phos- 
phate co-precipitation [10]. "/'he CAT fusion gene plasmid was eo- 
transfected with pCHI I0. an expression plasmid of,//-galactosidase [9] 
as an internal control. For chicken myoblasts, cells were allowed to 
grow for about i 8-20 h after plating and were then transfec'od with 
the fusion gene DNAs. The cells were still myoblasts within 24 la after 
transfection and fused to form myotubes during the next 24 h. Thus. 
the cells were harvested 20 h and 55 h after transfcction and were 
regarded as myoblasts and myotubes, respectively. 
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3. RESULTS 
3. l. Activation of the expression of the M-type aldolase 
A mRNA in myogenesis 
M-type aldolase A mRNA is expressed predominant- 
ly in skeletal muscle of the adult rat. This suggests that, 
as reported for many other muscle-specific genes, the 
expression of the mRNA could be activated uring dif- 
ferentiation of skeletal muscle. S1 nuclease analysi~ was 
performed to analyze the M-type mRNA in fetal leg 
muscle differentiation. In early fetal stages aldolase A 
mRNA was almost exclusively of the AH-type. The 
expression of M-type mRNA was drastically induced 
immediately before birth, continued to increase after 
birth with concomitant decrease of AH-type mRNA, 
and finally became a sole mRNA species of aldolase A 
in skeletal muscle of adult rat (unpublished results and 
[6]). 
3.2. Induction of M promoter fusion gene expression in 
chicken primary myoblast cells 
To analyze the change in M promoter activity during 
myogenesis, pM663CAT was constructed by inserting 
the M promoter fragment spanning between 663 base 
pairs upstream (-663 bp) and 41 bp downstream (+41 
bp) of the transcription i itiation site into the upstream 
site of the CAT coding sequence in plasmid pOA/CAT 
(Fig. I A). The plasmid (pM663CAT) was transfected 
into primary myoblasts prepared from breast muscle of 
l l-day-old chicken embryos. After transfection there 
was very low expression of CAT activity in myoblasts 
but this increased rastically (about 20-fold) in myotu- 
bes (Fig. 1B and C). Essentially the same result was 
obtained with a fusion gene construct having a longer 
upstream region (about 3000 bp) frc, m the promoter 
(data not shown). 
To identify the regulatory element(s) responsible for 
this induction, a series of unidirectional 5' deletion 
mutants were constructed (Fig. I A) and their CAT ex- 
pression in both cells was determined (Fig. 1B and C). 
pM202CAT also showed a drastic increase (17.5-fold) 
during myogenesis, while pM85CAT showed only a 
slight increase (3-fold) during the same culture period, 
although both pM202CAT and pM85CAT showed 
nearly the same CAT activities in myoblast cells. 
pM33CAT expressed very low levels of CAT activity in 
both types of cells. 
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Fig. I. Ihduction of expression of I~A promoter-CAT fusion genes 
during differentiation of primary chicken myoblast cultures. (A) 
Structures of M promoter-CAT fusion genes. M promoter sequence 
in all constructs tarts from 41 bp downstream of the transcription 
initiation site. The upper four are 5' deletion mutants and are designat- 
ed as pMxxCAT, where xx indicates the size of the 5' upstream region 
in bp. Tile lower two, pM85.a+CAT and pM85.a-CAT, are derivati- 
ves of pM85CAT with the fragment from -85 to -202 inserted into 
the vector egion about 2700 bp from the M promoter region m either 
orientation. (B) CAT activities expressed from M-CAT fusion genes. 
2.5 gg of pM-CAT was cotransfected with 5/,tg of pCH110 DNA. 
CAT activities expressed in chicken myoblasts (hatched bars), in 
chicken myotubes (filled bars) and in HepG2 (open bars) were 
quantified and were compared for equal activities of/S-gal. CAT ac- 
tivities are presented inrelative values assuming the CAT activity from 
pM663CAT in myotube to be I0. (C) The ratio of CAT activities in 
myotubcs to those in myoblasts. Activities of pM33CAT in both cells 
were very low and were, thus, omitted. 
Fusion gene plasmids, pM85,a+CAT and pM85.a- 
CAT, also showed the induction of CAT activities dur- 
ing myogenesis (about 10-fold) (Fig. I B), When the pM- 
CAT plasmids were transfected into HepG2, the activi- 
ties from the plasmids in HepG2 cells were negligible 
(Fig. 1B). This suggests that the activity of the M pro- 
moter in these fusion genes is cell type-specific. 
3.3. Men tificution of cis-regulatory elements in A H pro- 
moter with 5' deletion mutants 
When the whole rat aldolase A gene was transl'ected 
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Fig. 2. Expression of 5' deletion mutants of AH promoter-CAT fusion 
genes. (A) Structures of AH-CAT fusion genes. The genomic region 
from oxen M to oxen AH is shown schematically with identified 
promoter and enhancer elements, such as TATA box (*), CAT box 
(o), Spl-binding site [I 3] (~), APl-binding site [I 1] (c), CRE [22] (e), 
and NFl-binding site [23] (t~) in the above. AH promoter sequence in 
all AH-CAT fusion genes tarts at a site 16 bp downstream from the 
transcription i itiation site of mRNA III and as a result, the initiation 
site of mRNA II is excluded [3]. AH-CAT fusion genes were designat- 
ed as pAHxxCAT, the same as M-CAT fusion genes. (B) Expression 
of the fusion genes in HepG2 cells. CAT activities are presented in 
values relative to that of pAH293CAT, which is considered as 10. 
Transfection efficiency was normalized to the fl-gal activity expressed 
from co-transfected pCH110. 
into HepG2, AH-type mRNA starting from the authen- 
tic initiation sites was detected by RNase mapping, and 
the expression level was not affected by shortening the 
upstream region of the AH exon from 800 bp to 300 bp 
(unpublished data). Thus we focused our efforts on ana- 
lyzing the 300 bp upstream region of the AH exert by 
constructing AH promoter-CAT fusion genes. 
To determine the promoter activities, a series of 5' 
deletion mutants were constructed (Fig. 2). As seen in 
Fig. 2B, deletion of 2 regions was found to decrease the 
CAT activity; one between -279 bp and -268 bp and 
the other between -207 bp and -198 bp. Deletion of the 
distal region caused about a 2-fold decrease in the CAT 
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Fig. 3. Expression of internal mutants of AH-CAT fusion genes. Five 
mutations are described in the sequence between -240 bp and -121 
bp of AH promoter. All mutants were constructed from pAH293CAT. 
The position of the mutated sequence is indicated in parentheses under 
the mutant. The deletion end points of the three 5' deletion mutants 
are also shown above the sequence. CAT activities were normalized 
to,6-gal and are presented in relative values as in Fig. 2. 
activity (pAH279CAT to pAH268CAT), while deletion 
of the proximal region resulted in a 60- to 70-fold de- 
crease of the CAT activity (pAH207CAT to 
pAH 198CAT). The APl-binding sequence was found to 
locate exactly in the distal region (-276 to -270, see Fig. 
4B) [11]. Thus this cis-element could be responsible for 
the AH promoter activity in HepG2 cells. Further dele- 
tion caused a greater decrease of about 3-fold 
(pAH198CAT to pAHI77CAT). However, in this re- 
gion no previously reported regulatory elements were 
found [12]. Therefore, this region was analyzed in detail 
by constructing linker scanning (LS) mutants and an 
internal deletion (ID) mutant. 
3.4. Analysis of sequences required for AH promoter ac- 
tivity in the proximal region 
Four LS mutants and an ID mutant were constructed 
by introducing local changes of short sequences into the 
-220 to -140 region of pAH293CAT (Fig. 3). Muta- 
tions in positions -219 to -215 (pAH293-LS 1 CAT) and 
-143 to -138 (pAH293-LS4CAT), which locate outside 
the proximal regions, were found to show no effect on 
the promoter activity. On the other hand, 3 mutants, 
pAH293-LS2CAT ( -  193 to - 180), pA, H293-LS3CAT 
130 
Volume 292, number 1,2 
A 
FEB$ LETTERS 
-180 -150 • • v , • 
TAGGCAGGGATGAATGTCAGGGGCCTC~%GGTTTCA~TARATATAGGTC~TTC~CCGC GGGA 
I I I I !  f i l l  I l l  
CTAAAAATAGCTCC 
T T T A CTT 
-i00 
TTCGTGGTGGGGAAAGGGCAGAGGTTATGGAGAAGGTCCGGGGACACTGGTGCGGGGGTG 
November 1991 
-5O 
CGTAGGGGAGGGGTGGAGAGTAGGAGCTGC6TTATAACCCkGCCCTGGC~CGCGGGGC~ 
-300 
S CTCCTCGCCAATCCACATTC6GC-C~GATGCTCG6.GCGCGCGCCAGACAGGGAC 
-200  
TGGGGGAGG~GGCTAGGGCCTGGTGACCTGAGGGATGTGGCTCGAGTCACGTCCTAC-CG 
GGGCGGAGGAGGGATCTAGTTCTAGCCGCTTGTCTCCTCCCCAGC GCCC CTCCTATCGT 
-i00 
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-I 
CAAGGGAAA~CCTGCAGCG~CGGGGCGG6 GCCTTTAAATGTCCGGGC~CCCGCCTCCC 
Fig. 4. Nucleotide sequence of M and AH promoter egions, (A) The sequence between 180 bp to 1 bp upstream ofexon M is shown. Shaded area 
is the putative MEF-2 binding site, A consensus sequence for MEF-2 binding is shown below [16,17]. Bars indicate identical nucleotides. TATA 
box is broken line. (B) The sequence between 300 bp to 1 bp upstream ofexon AH1 is shown. Shaded region is the APl-binding site. Inverted 
repeat sequence is indicated with a pair of arrows. Four Spl-binding sites are underlined. CAT box and TATA box are wavy and broken lines, 
respectively. 
( -  175 to - 167), and pAH293-ID 1 CAT (-207 to -200), 
showed ecreased expression of CAT (Fig. 3). In partic- 
ular, the mutations in pAH293-LS2CAT and pAH293- 
ID1CAT showed remarkable effects on the AH promo- 
ter activity (20- and 5-fold decrease, respectively), sup- 
porting the premise that the proximal region is impor- 
tant for promoter activity. On the contrary, pAH293- 
LS3CAT showed only a moderate ffect on promoter 
activity (2-fold decrease). Since the mutation destroyed 
one of four Spl-binding sites [13] in the 300 bp promo- 
ter region as follows, GGGCGG to GGGCGC (Fig. 3), 
it is likely that a loss of Spl-binding to the site caused 
the decrease of promoter activity in LS3 mutant. 
4. DISCUSSION 
4. i. A muscle-specific enhancer in the M pronloter 
M-CAT fusion genes, pM663CAT and pM202CAT, 
showed a dramatic appearance ofexpression i  associa- 
tion with myogenesis when they were transfected into 
chicken primary myoblasts. These results strongly sug- 
gest that the induction of M-type mRNA in rat fetal leg 
muscle resulted from transcriptional ctivation of the M 
promoter. Our results showed that a 202 bp upstream 
region of the M1 exon is sufficient for the promoter 
activation coordinated with myogenic differentiation 
(Fig. 1B and C). Deletion of the sequence between -202 
bp and -85 bp greatly decreased the induction effi- 
ciency during myogenesis but did not affect he expres- 
sion in myoblasts. This indicated that a sequence(s) in 
this region does not function in myoblasts but functions 
positively on the expression i  myotubes. This putative 
upstream regulatory element functioned independently 
of orientation and distance from the promoter, and 
therefore exhibited the properties of an enhancer. In this 
region no Myo DI binding sequence [14] or CArG box 
[15] was found. Instead an AT-rich sequence, so-called 
MEF-2 binding sequence [16,17], was observed (Fig. 
4A). Thus, this element could be responsible for the M 
promoter induction in myotube. 
4.2. Regulatory elements in Al-I promoter 
A 293 bp upstream sequence of the transcription i i- 
tiation site was found to be sufficient for the promoter 
activity. Two regions required for the activity were iden- 
tified in this flanking sequence; distal region (-279 to 
-268) and proximal region (-207 to -198). A sequence 
for APl-binding was within the distal region (-276 to 
270, see Fig. 4B). Thus the decrease in the promoter 
activity should be due to the loss of APl-binding to the 
promoter. 
Another region, the proximal region, was identified 
by a deletion from -207 bp to -198 bp. As a result of 
this deletion, the 5' end of the proximal element seemed 
to be located between -207 and -198. In this region we 
could not find any of the promoter or enhancer core 
sequences previously reported but identified an almost 
complete inverted repeat sequence, a pair of l l-bp se- 
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quences with 2 mismatches (see horizontal arrows in 
Fig. 4B). When the inverted repeat is assumed to be 
required for the promoter activity, it becomes clear that 
the promoter activities of ID als LS mutants AH-CAT 
fusion genes howed good correlation with the extent of 
destruction of the inverted repeat sequence. These 
results thereofore strongly suggest that the inverted 
repeat is important for the promoter activity. 
The human aldolase A gene has also been cloned, and 
its structure was analyzed by several aboratories in- 
cluding ours [18-20]. The homology of these exons be- 
tween rat and human is very high. A high homology is 
also found between the upstream regions of the exons, 
especially between -300 bp regions (data not shown). 
Although Izzo et al. [21] observed a major decrease 
(about one third) of promoter activity when the up- 
stream region between -384 and -262 (corresponding 
to the distal region in ours) was deleted, no remarkable 
decrease in expression was observed by deleting the 
region corresponding to the proximal region of the rat 
promoter. The inverted repeat found in the rat promot- 
er was also found in the corresponding position in the 
human promoter, although the human repeat carries 2 
additional mismatches. 
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